These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27117040)

  • 41. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The necessity to assess anticoagulation status in elderly injured patients.
    Williams TM; Sadjadi J; Harken AH; Victorino GP
    J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derangement of warfarin anticoagulation by miconazole oral gel.
    Pemberton MN; Sloan P; Ariyaratnam S; Thakker NS; Thornhill MH
    Br Dent J; 1998 Jan; 184(2):68-9. PubMed ID: 9489213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of Warfarin Anticoagulant Reaction in Patients with Repeated Oral Tolvaptan Administration.
    Saito M; Ajioka M; Iwao T; Suzuki T
    Biol Pharm Bull; 2018 Jul; 41(7):1014-1016. PubMed ID: 29760305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.
    Berg TM; O'Meara JG; Ou NN; Daniels PR; Moriarty JP; Bergstrahl EJ; Dierkhising RA; Manning DM
    Pharmacotherapy; 2013 Nov; 33(11):1165-74. PubMed ID: 23625787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
    Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
    Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.
    MacCallum P; Madhani M; Mt-Isa S; Ashby D
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):786-9. PubMed ID: 17111459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 52. Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.
    Wittkowsky AK; Sekreta CM; Nutescu EA; Ansell J
    Pharmacotherapy; 2005 Feb; 25(2):265-9. PubMed ID: 15767240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding.
    Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions to improve anticoagulation with warfarin.
    Castro TA; Heineck I
    Ther Drug Monit; 2012 Apr; 34(2):209-16. PubMed ID: 22406649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study.
    Andersson ML; Mannheimer B; Lindh JD
    Eur J Clin Pharmacol; 2019 Oct; 75(10):1387-1392. PubMed ID: 31201436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of feeding state on anticoagulation in adult goats treated with warfarin.
    Date K; Kishimoto S; Fujii Y; Togo K; Kakuta Y; Mizuno T; Tsukiya T; Takewa Y; Nishimura T; Ono M; Tatsumi E
    J Artif Organs; 2016 Sep; 19(3):301-4. PubMed ID: 26815203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased sensitivity to warfarin in elderly Hispanics.
    Casner PR; Sandoval E
    J Clin Pharmacol; 2002 Feb; 42(2):145-50. PubMed ID: 11831536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of warfarin anticoagulant activity by miconazole oral gel.
    Ariyaratnam S; Thakker NS; Sloan P; Thornhill MH
    BMJ; 1997 Feb; 314(7077):349. PubMed ID: 9040331
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of converting from pravastatin to simvastatin on the pharmacodynamics of warfarin.
    Lin JC; Ito MK; Stolley SN; Morreale AP; Marcus DB
    J Clin Pharmacol; 1999 Jan; 39(1):86-90. PubMed ID: 9987704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.